Tag: Prescription Drugs
Treatment Effect of Tofacitinib, Adalimumab Compared in RA
Modest reduction seen in DAS28-CPR at three months for those receiving TOF versus ADA, but no difference seen at nine months
Pharmacy-Level Stewardship Can Save on Immune Checkpoint Inhibitors
Strategies include dose rounding and vial sharing, as well as weight-based dosing
European Regulators Investigating Risk for Suicidal Thoughts With Popular Weight-Loss Drugs
Three case reports from Iceland spurred the review; two of the cases involved Ozempic
Stimulant Treatment for Childhood ADHD Not Linked to Substance Use
No evidence seen for link between childhood stimulant treatment and substance use during adolescence and young adulthood
Variation Seen in Dosing of Meds at Prehospital Pediatric Encounters
Lowest consistency with guidelines was seen for diazepam and lorazepam; most deviations represented an underdose
P2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
Reduced risk seen for composite of cardiovascular death, myocardial infarction, and stroke
Therapeutic Value of Drugs Lower for Supplemental Versus First Indications
For first three approved indications, second and third indication approvals less likely to have high value rating
Mirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
Mirikizumab more effective for inducing and maintaining clinical remission in patients with ulcerative colitis
Long-Acting ART Achieves Virologic Suppression for People With HIV
97.5 percent were projected to achieve virologic suppression by a median of 33 weeks
Medical Cannabis Laws Seem Not to Have Affected Opioid, Nonopioid Therapy
No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain
